229 related articles for article (PubMed ID: 33849485)
21. Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma.
Koh KN; Namgoong JM; Yoon HM; Cho YA; Choi SH; Shin J; Kang SH; Suh JK; Kim H; Oh SH; Kim KM; Kim DY; Im HJ
Cancer Med; 2021 May; 10(10):3261-3273. PubMed ID: 33939313
[TBL] [Abstract][Full Text] [Related]
22. Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China.
Wang TY; Han YL; Gao YJ; Xu M; Gu S; Yin MZ; Zhong YM; Hu WT; Pan C; Tang JY
Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):471-478. PubMed ID: 31000431
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study.
Aronson DC; Schnater JM; Staalman CR; Weverling GJ; Plaschkes J; Perilongo G; Brown J; Phillips A; Otte JB; Czauderna P; MacKinlay G; Vos A
J Clin Oncol; 2005 Feb; 23(6):1245-52. PubMed ID: 15718322
[TBL] [Abstract][Full Text] [Related]
24. Analysis of factors related to recurrence of paediatric hepatoblastoma - a single Centre retrospective study.
Yang W; Chen Y; Huang Y; Wang H
BMC Pediatr; 2019 Dec; 19(1):485. PubMed ID: 31822277
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
[TBL] [Abstract][Full Text] [Related]
26. Multidisciplinary effort in treating children with hepatoblastoma in China.
Yuan XJ; Wang HM; Jiang H; Tang MJ; Li ZL; Zou X; Fang YJ; Pan C; Tou JF; Zhang KR; Liu X; Li WS; Li Y; Lu J; Wu YM
Cancer Lett; 2016 May; 375(1):39-46. PubMed ID: 26945966
[TBL] [Abstract][Full Text] [Related]
27. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
Meyers RL; Rowland JR; Krailo M; Chen Z; Katzenstein HM; Malogolowkin MH
Pediatr Blood Cancer; 2009 Dec; 53(6):1016-22. PubMed ID: 19588519
[TBL] [Abstract][Full Text] [Related]
28. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
29. CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China.
Huang J; Hu Y; Jiang H; Xu Y; Lu S; Sun F; Zhu J; Wang J; Sun X; Liu J; Zhen Z; Zhang Y
Front Oncol; 2020; 10():552079. PubMed ID: 33312943
[TBL] [Abstract][Full Text] [Related]
30. Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: A Chinese population-based study.
Jiao C; Zhu A; Jiao X; Ge J; Xu X
J Pediatr Surg; 2016 Aug; 51(8):1355-61. PubMed ID: 27046304
[TBL] [Abstract][Full Text] [Related]
31. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED; Tiao GM; O'Neill AF; Qayed M; Furman WL; Xia C; Rodriguez-Galindo C; Meyers RL
Lancet Oncol; 2019 May; 20(5):719-727. PubMed ID: 30975630
[TBL] [Abstract][Full Text] [Related]
32. Hepatoblastoma. Clinical experience at a single institution using the Siopel staging system.
Leal-Leal CA; Imaz-Olguín V; Robles-Castro J; Shalkow-Klincovstein J; Palacios-Acosta JM
Ann Hepatol; 2010; 9(1):75-9. PubMed ID: 20308725
[TBL] [Abstract][Full Text] [Related]
33. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
[TBL] [Abstract][Full Text] [Related]
34. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
Suita S; Tajiri T; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
[TBL] [Abstract][Full Text] [Related]
35. Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study.
Ren X; Li H; Diao M; Xu H; Li L
Int J Clin Oncol; 2020 Apr; 25(4):765-773. PubMed ID: 31701290
[TBL] [Abstract][Full Text] [Related]
36. Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
Uchida H; Sakamoto S; Sasaki K; Takeda M; Hirata Y; Fukuda A; Hishiki T; Irie R; Nakazawa A; Miyazaki O; Nosaka S; Kasahara M
Pediatr Blood Cancer; 2018 Dec; 65(12):e27383. PubMed ID: 30084209
[TBL] [Abstract][Full Text] [Related]
37. Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan.
Hsu WY; Chang HH; Lu MY; Yang YL; Jou ST; Chen HL; Ni YH; Hsu HY; Chang MH; Wu JF
Pediatr Neonatol; 2020 Aug; 61(4):393-398. PubMed ID: 32291200
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for event-free survival in liver transplantation for hepatoblastoma: A single-center experience.
Lauferman L; Halac E; Aredes D; Cañon Reyes I; Cervio G; Dip M; Minetto J; Reijenstein H; Meza V; Gole M; Jacobo Dillon A; Rose A; Imventarza O
Pediatr Transplant; 2019 Dec; 23(8):e13581. PubMed ID: 31531932
[TBL] [Abstract][Full Text] [Related]
39. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.
Trobaugh-Lotrario A; Katzenstein HM; Ranganathan S; Lopez-Terrada D; Krailo MD; Piao J; Chung N; Randazzo J; Malogolowkin MH; Furman WL; McCarville EB; Towbin AJ; Tiao GM; Dunn SP; Langham MR; McGahren ED; Feusner J; Rodriguez-Galindo C; Meyers RL; O'Neill AF; Finegold MJ
J Clin Oncol; 2022 Feb; 40(5):459-467. PubMed ID: 34874751
[TBL] [Abstract][Full Text] [Related]
40. Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach.
Srinivasan S; Prasad M; Parambil BC; Shrimal A; Gollamudi VRM; Subramani V; Ramadwar M; Khanna N; Baheti AD; Gala K; Patil V; Laskar S; Qureshi S; Chinnaswamy G
Pediatr Blood Cancer; 2023 Jul; 70(7):e30302. PubMed ID: 37046413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
